- Price
- $10.85
- Day
- -0.28%
- Mkt Cap
- $1.81B
- 52W Range
- $6.07 – $17.48
- Volume
- 2.99M
- Beta
- 1.01
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
FIGS, Inc. is upgraded from ‘sell' to ‘hold' as valuation now reflects fair value after a 16% share price decline and continued growth. FIGS delivered 28% YoY revenue growth in Q1 2026, driven by a 12% increase in active customers and higher net revenue per customer. Management guides for 14–16% revenue growth and a 27.7% EBITDA increase in 2026, supported by a strong net cash position of $277 million.
Read full article
Arrowstreet Capital Limited Partnership increased its stake in shares of FIGS, Inc. (NYSE: FIGS) by 167.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,070,258 shares of the company's stock after buying an additional 2,546,905 shares during the
Read full article
Castleark Management LLC acquired a new stake in FIGS, Inc. (NYSE: FIGS) during the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 199,010 shares of the company's stock, valued at approximately $2,939,000. Castleark Management LLC owned 0.12% of FIGS as of its most
Read full article
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a second quarter 202.
Read full article
FIGS' record-high net revenues per active customer signal stronger spending, higher purchase frequency and engagement as the company lifts its 2026 outlook.
Read full article
Figs (FIGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read full article